ISRCTN36383299已完成不适用
Terlipressin versus albumin in the prevention of paracentesis associated adverse events in patients with cirrhosis and tense ascites: a multicentre randomised controlled trial
Foundation for Liver and Gastrointestinal Research (SLO) (Netherlands)0 个研究点目标入组 84 人开始时间: 2006年1月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Cirrhosis with tense ascites requiring therapeutic paracentesis
- •2. Aged 18 - 70 years
- •3. Written informed consent
排除标准
- •1. Hypertension treated with medication
- •2. History of cardiac or coronary disease
- •3. Circulatory unstable
- •4. Until 5 days prior to paracentesis:
- •4.1. Infusion of a plasma expander
- •4.2. Gastro-intestinal haemorrhage
- •4.3. Spontaneous bacterial peritonitis
- •5. Systemic administration of antibiotics within the past 14 days for a period of more than 24 hours, with the exception of quinolones
- •6. Hepatocellular carcinoma
- •7. Hepatic encephalopathy
- •8. Pregnancy or lack of adequate contraception in sexually active females
- •9. Any other condition which in the opinion of the investigator would make the patient unsuitable for enrolment, or could interfere with the patient participating in and completing the study
研究者
相似试验
已完成
不适用
Terlipressin versus albumin in the prevention of paracentesis associated adverse events in patients with cirrhosis and tense ascites. A multicenter randomised controlled trial.NL-OMON23876Foundation for Liver Research (SLO)Erasmus MCc/o department of hepatology and gastroenterology,room Ca 326Dr. Molewaterplein 403015 GD Rotterdamtel (010) 463 594284
已完成
不适用
Efficacy of early terlipressin (drug) in ACLF (Liver Disease)CTRI/2020/06/026006Institute of Liver and Biliary Sciences70
尚未招募
2 期
Comparison of Terlipressin and low dose Terlipressin and noradrenalin in HRS-AKI patients of ACLFCTRI/2023/10/058546on sponsered
已完成
不适用
Terlipressin in liver failureCTRI/2019/10/021737o sponsor required116
招募中
3 期
Effect of Terlipressin Drug in Patients with Liver Cancers undergoing surgeryCTRI/2021/11/038076Tata Memorial Hospital